Cargando…
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
Newly approved cancer drugs called ICIs have shown remarkable success in improving patient survival rates, but they also have the potential for inflammatory and immune-related side effects, including those affecting the cardiovascular system. Research has been conducted to understand the development...
Autores principales: | lessomo, Fabrice Yves Ndjana, Mandizadza, Oscar Onayi, Mukuka, Chishimba, Wang, Zhi-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631013/ https://www.ncbi.nlm.nih.gov/pubmed/37941006 http://dx.doi.org/10.1186/s40001-023-01464-1 |
Ejemplares similares
-
Comparative cardiotoxicity risk of pembrolizumab versus nivolumab in cancer patients undergoing immune checkpoint inhibitor therapy: A meta-analysis
por: Ndjana Lessomo, Fabrice Yves, et al.
Publicado: (2023) -
The relationship between leukocyte to albumin ratio and atrial fibrillation severity
por: Lessomo, Fabrice Yves Ndjana, et al.
Publicado: (2023) -
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
por: Luo, Xinyi, et al.
Publicado: (2023) -
Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017) -
Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)